维普中文期刊产品整合服务
92篇 您的检索式:作者名="Jankus"
    题名 作者 年代 出处 被引量
1临汾方志传记中的灾害体验1600-1900显示文摘中国灾害史的研究视野,受到中国王朝更迭—灾害增加的互动范式以及中华帝国注定失败论范式的双重影响,从社会史及文化史层面深入探索中国灾害史的实证性研究尚不多见。本文选取史料特征不太显著的方志传记入手,研究其中隐含着的灾害体验的社会文化内容,并进而探讨中国灾害史的研究方法。安维雅(Andrea Janku) 曹新宇(译) 刘希付(译) 2009清史研究2009,,1:6
2左氧氟沙星、加替沙星及莫西沙星对肺结核患者的早期及延长早期杀菌活性显示文摘目的:评估左氧氟沙星、加替沙星及莫西沙星等新氟喹诺酮类药物对肺结核患者的早期杀菌活性及延长早期杀菌活性。设计:随机开放临床试验。40例成年新诊断的涂阳肺结核患者(每组10例)分别每日单一接受异烟肼300mg,或左氧氟沙星1000mg,或加替沙星400mg,或莫西沙星400mg的7天治疗。治疗前2天及单药治疗7天期间,每日收集痰液进行定量培养。计量单药治疗开始的头2天(0-2天)及治疗后5天(2-7天)的菌量下降情况,以评估各药的早期及延长早期杀菌活性。对实验室工作人员关于病人治疗分组信息采用单盲法。结果:异烟肼的早期杀菌活性为0.67log10cfu/毫升/天,高于莫西沙星(0.33log10cfu/毫升/天)及加替沙星(0.35log10cfu/毫升/天)。与每日1000mg左氧氟沙星的早期杀菌活性(0.45log10cfu/毫升/天)相比,无统计学差异(P=0.14)。3种氟喹诺酮类药物的早期杀菌活性(0-2天)与延长早期杀菌活性(2-7天)相似。总体说来,氟喹诺酮类药物的延长早期杀菌活性高于异烟肼。结论:莫西沙星、加替沙星及高剂量左氧氟沙星,虽然略低于异烟肼,但均有良好的早期杀菌活性,并具有较高的延长早期杀菌活性。有理由对这些药物敏感的结核病人进行进一步的治疗研究。J. L. Johnson D. J. Hadad W. H. Boom C. L. Daley C. A. Peloquin K. D. Eisenach D. D. Jankus S. M. Debanne E. D. Charlebois E. Maciel M. Palaci R. Dietzet 马玙(译) 屠德华(校) 张立兴(审) 2006国际结核病与肺部疾病杂志2006,1,2:5
3Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer显示文摘Kopetz Scott Desai Jayesh Chan Emily Hecht Joel Randolph O’Dwyer Peter J. Maru Dipen Morris Van Janku Filip Dasari Arvind Chung Woonbook Issa Jean-Pierre J. Gibbs Peter James Brian Powis Garth Nolop Keith B. Bhattacharya Suman Saltz Leonard 2015Journal of Clinical Oncology2015,,34:2
4PIK3CA Mutations Frequently Coexist with RAS and BRAF mutations in Patients with Advanced Cancers显示文摘Janku F Lee JJ Tsimberidou AM 2011PLoS One2011,6,22:1
5PIK3CA mutations in patients with advanced cancers treated with PI3K/ AKT/mTOR axis inhibitors 显示文摘Janku F Tsimberidou AM Garrido-Laguna I 2011Mol Cancer Ther2011,10,3:1
6Molecular targets fbr cancer therapy in the PI3K/AKT/mTOR pathway显示文摘Polivka J Jr Janku F 2014Pharmacol Ther2014,142,2:1
7Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway 显示文摘Polivka J Janku F 2014Pharmacol Ther2014,142,2:1
8Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA显示文摘Janku F Srovnal J Korinkova G 2008Neoplasma2008,55,4:1
9Novel therapeutic targets in non-small cell lung cancer显示文摘Janku F Garrido-Laguna I Petruzelka LB 2011J Thorac Oncol2011,6,9:1
10PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations显示文摘Janku F Wheler J J Westin S N 0,,08:1
11Autophagy as a target for anticancer therapy显示文摘Janku F McConkey D J Hong D S 2011Nat Rev Clin Oncol2011,8,9:1
12PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors 显示文摘Janku F Tsimberidou AM Garrido-Laguna I 2011Mol Cancer Ther2011,10,3:1
13Intratumoral injection of clostridium novyi NT spores induces antitumor responses显示文摘Roberts N J Zhang L Janku F 2014Sci Trans Med2014,6,249:1
14Autophagy as a target for anticancer therapy显示文摘Janku F McConkey D J Hong D S 2011Nat Rev Clin Oncol2011,8,9:1
15Pharmacokinetics of carfecillin and carindacillin 显示文摘Modr Z Dvoracek K Janku I 1977International Journal of Clinical Pharmacology and Biopharmacy1977,15,2:1
16Targeted therapy in non- small cell lung cancer: is it becoming a reality? 显示文摘Janku F Stewart D J Kurzrock R 2010Nat Rev Clin Onco12010,7,7:1
17The Van der Woude Syndrome in a large kindred:Variability,penetrant,geneticrisks显示文摘Janku P Robinow M Kelly T 0,,:1
18Molecular targets for cancer therapy in thePI3K/AKT/mTOR pathway 显示文摘Polivka J Jr Janku F 2014Pharmacol Ther2014,142,2:1
19KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients显示文摘Janku F Novotny J Julis I 2005Melanoma Res2005,15,4:1
20Autophagy as a target for anticance therapy 显示文摘Janku F McConkey DJ Hong DS 2011Nat Rev Clin Onco12011,8,9:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费